SITC is the world’s leading member society of medical professionals dedicated to advancing cancer immunotherapy and biological therapy through its initiatives, educational sessions, and collaborative endeavors. SITC has become the premier forum for innovative discussions in the field and remains a central provider of scientific information for its diverse members serving in academia, industry, and regulatory agencies in the U.S. and abroad.
SITC Spokespeople in the Newsroom |
||||
Lisa H. Butterfield, PhD SITC President |
Bernard A. Fox, PhD Tumor Immunology Specialist |
|||
Submit interview requests here. |
||||
Media Resources Informational and educational materials on cancer immunotherapy, including interviews with experts in the field |
SITC Press Releases Late-breaking news from the Society for Immunotherapy of Cancer |
|||
Immunotherapy in the News The science of cancer immunotherapy is rapidly advancing; see what other journalists are saying |
Immune Monitor View SITC’s latest eNewsletter for Society insider information |
|||
SITC Press Registration Form |
For all media inquiries, please contact SITC at +1 414-271-2456 or info@sitcancer.org.